Trial Profile
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 13 Jan 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Planned initiation date (Oct 2009) added as reported by ClinicalTrials.gov.
- 14 Dec 2010 New trial record